Japan's BioComo Pursues Novel Ligand Approach To Immuno-Oncology

Avoids 4-1BB/OX-40 Toxicity Issues

Dividing breast cancer cell
Ligand Approach Holds Potential In Cancer • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Japan

More from Focus On Asia